Eledon Pharmaceuticals Stock Forward View - Accumulation Distribution
| ELDN Stock | USD 2.09 0.04 1.88% |
Eledon Stock outlook is based on your current time horizon.
As of today the rsi of Eledon Pharmaceuticals' share price is below 20 suggesting that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
Using Eledon Pharmaceuticals hype-based prediction, you can estimate the value of Eledon Pharmaceuticals from the perspective of Eledon Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
Eledon Pharmaceuticals after-hype prediction price | USD 2.15 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Eledon Pharmaceuticals to cross-verify your projections. Eledon Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Eledon price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Eledon using various technical indicators. When you analyze Eledon charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 21082.17 | 22358.89 |
| Check Eledon Pharmaceuticals Volatility | Backtest Eledon Pharmaceuticals | Information Ratio |
Eledon Pharmaceuticals Trading Date Momentum
| On February 10 2026 Eledon Pharmaceuticals was traded for 2.09 at the closing time. The top price for the day was 2.17 and the lowest listed price was 2.06 . The trading volume for the day was 441.1 K. The trading history from February 10, 2026 did not affect price variability. The overall trading delta against the current closing price is 1.91% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare Eledon Pharmaceuticals to competition |
Other Forecasting Options for Eledon Pharmaceuticals
For every potential investor in Eledon, whether a beginner or expert, Eledon Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Eledon Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Eledon. Basic forecasting techniques help filter out the noise by identifying Eledon Pharmaceuticals' price trends.Eledon Pharmaceuticals Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Eledon Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Eledon Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Eledon Pharmaceuticals by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Eledon Pharmaceuticals Market Strength Events
Market strength indicators help investors to evaluate how Eledon Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Eledon Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Eledon Pharmaceuticals stock market strength indicators, traders can identify Eledon Pharmaceuticals entry and exit signals to maximize returns.
| Accumulation Distribution | 22358.89 | |||
| Daily Balance Of Power | (0.36) | |||
| Rate Of Daily Change | 0.98 | |||
| Day Median Price | 2.12 | |||
| Day Typical Price | 2.11 | |||
| Price Action Indicator | (0.04) | |||
| Period Momentum Indicator | (0.04) |
Eledon Pharmaceuticals Risk Indicators
The analysis of Eledon Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Eledon Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting eledon stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.47 | |||
| Semi Deviation | 4.17 | |||
| Standard Deviation | 4.66 | |||
| Variance | 21.75 | |||
| Downside Variance | 24.63 | |||
| Semi Variance | 17.42 | |||
| Expected Short fall | (4.05) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Eledon Pharmaceuticals
The number of cover stories for Eledon Pharmaceuticals depends on current market conditions and Eledon Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Eledon Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Eledon Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Eledon Pharmaceuticals Short Properties
Eledon Pharmaceuticals' future price predictability will typically decrease when Eledon Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Eledon Pharmaceuticals often depends not only on the future outlook of the potential Eledon Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Eledon Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 48.5 M | |
| Cash And Short Term Investments | 140.2 M |
Check out Historical Fundamental Analysis of Eledon Pharmaceuticals to cross-verify your projections. To learn how to invest in Eledon Stock, please use our How to Invest in Eledon Pharmaceuticals guide.You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Will Biotechnology sector continue expanding? Could Eledon diversify its offerings? Factors like these will boost the valuation of Eledon Pharmaceuticals. Projected growth potential of Eledon fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Eledon Pharmaceuticals data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Understanding Eledon Pharmaceuticals requires distinguishing between market price and book value, where the latter reflects Eledon's accounting equity. The concept of intrinsic value - what Eledon Pharmaceuticals' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Eledon Pharmaceuticals' price substantially above or below its fundamental value.
It's important to distinguish between Eledon Pharmaceuticals' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Eledon Pharmaceuticals should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Eledon Pharmaceuticals' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.